LEI 549300XX4Z71K4PSGS85

Pharma Holdings AS

Awards tracked

11

Value

€859,566

NOK 10.49M

Countries

NO

Download sample CSV

Contract awards & public grants

PHARMA HOLDINGS AS — Distriktsutviklingstilskudd: Bedriftsutviklingstilskudd

Innovasjon Norge · NO · Grant · 2026-02-23

€260,870

PHARMA HOLDINGS AS — LTX-109. Broad spectrum anti-viral therapeutics for infectious diseases with epidemic potential

Norges forskningsråd · NO · Grant · 2023-01-01

NOK 299,998

PHARMA HOLDINGS AS — LTX-109 as a therapeutic and prophylactic agent for upper respiratory tract infections

Norges forskningsråd · NO · Grant · 2022-01-01

NOK 99,999

PHARMA HOLDINGS AS — Internasjonale tilskuddsprogrammer: Næringsutvikling og bistand

Innovasjon Norge · NO · Grant · 2021-07-27

€178,261

PHARMA HOLDINGS AS — Distriktsutviklingstilskudd: Bedriftsutviklingstilskudd

Innovasjon Norge · NO · Grant · 2021-03-10

€86,957

PHARMA HOLDINGS AS — Clinical testing program for use of LTX-109 as treatment against COVID-19 infection.

Norges forskningsråd · NO · Grant · 2021-01-01

NOK 399,998

PHARMA HOLDINGS AS — Ekstraordinære tiltak: Koronatiltak

Innovasjon Norge · NO · Grant · 2020-06-25

€173,913

PHARMA HOLDINGS AS — Development of the first of its kind medication for combined treatment of viral and bacterial conjunctivitis.

Norges forskningsråd · NO · Grant · 2020-01-01

NOK 99,999

PHARMA HOLDINGS AS — Nasal Decolonization to prevent post-surgical infections.

Norges forskningsråd · NO · Grant · 2020-01-01

NOK 9.59M

PHARMA HOLDINGS AS — Distriktsutviklingstilskudd: Bedriftsutviklingstilskudd

Innovasjon Norge · NO · Grant · 2019-12-17

€81,304

PHARMA HOLDINGS AS — Distriktsutviklingstilskudd: Bedriftsutviklingstilskudd

Innovasjon Norge · NO · Grant · 2019-06-03

€78,261

Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.